chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On June 08 I started to have a cardiac episode with severe chest pain, low heart rate, and lightheadedness. I walked to the ER from my office where an EKG was performed and my heart rate was 47. My blood was tested and my troponin levels were 47. I was given aspirin and waited for 11 hours to be seen before going home and arranging through work to see a cardiologist on Thursday, June 10th. I was given a heart monitor and an Angiogram was ordered. The angiogram came back clear. No blockages and no calcium build-up. An Echocarido was done and shows minimal tricuspid regurgitation. Prior to June 8th, I've never had heart issues. My physical fitness is good. My average resting heart rate is in the upper 50's or lower 60's normally. Now the week following my cardiac episode walking half a mile my heart rate was 125 to 175 where it would normally not be above 90. Over the past 3-weeks I've had less chest pain, my heart rate has risen back to normal levels and my walking heart rate is now in the 90's
At 1 am I woke with severe leg pain in both legs, Hugh fever nausea stomach issues and vomiting  The leg muscular pain has been so severe I have muscle pain over 48 hours later
Blood clot Soreness at the injection site Minor headache Minor chest pain Fatigue Swollen feet, ankle, and legs daily Treatment: A prescription of Xareltto
Pt states that the next day she was itching and then it slowly turned into hives around the 3 or 5 day, she did not come to me at the pharmacy until Aug 21, 12 days after I had administered her the vaccine, she was still having hives and itching.
Hives on back and arms; This is a spontaneous report received from a contactable consumer, the patient. A 57-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL 9261), via an unspecified route of administration in the left arm on 08Mar2021 at 11:30 (at the age of 57-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL 3302), via an unspecified route of administration in the left arm on 08Feb2021 at 11:45 as a single dose for COVID-19 immunisation. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. On 13Mar2021 at 15:00, the patient experienced hives on back and arms five days after second dose that still persisted. No therapeutic measures were taken for the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event hives on back and arms was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
eye discomfort; accidental exposure of vaccine; inadvertently splashed some in her eyes; inadvertently splashed some in her eyes while withdrawing it from vial into syringe; This spontaneous report was received from a nurse practitioner and refers to a 32-year-old, female patient. The patient was also a nurse. She was not pregnant. Her concurrent conditions included high blood pressure, dermatomyositis and hypothyroidism. Concomitant medications included lisinopril (manufacturer unknown) tablet, orally. Medical history was not reported. Not known drug allergies (NKDA).  On 03-MAR-2021, the nurse was drawing up varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter, lot # T021822, expiration date was reported and validated as 25-JUN-2022, for active immunization for the prevention of varicella. While withdrawing liquid from vial into syringe, she had inadvertently splashed some varicella virus vaccine live (oka/merck) (VARIVAX) and sterile diluent (dose, strength, frequency, lot # and expiration date were not provided) in her eyes (accidental exposure to product, occupational exposure to product and exposure via eye contact). She has been reporting some eye discomfort (ocular discomfort) but has also been irrigating her eye with 1 liter of irrigation solution. It was stated, that she sought medical attention. The action taken with sterile diluent was not reported (unknown). The outcome of ocular discomfort was reported as not recovered/not resolved. The causality between the suspect products and the event of eye discomfort was not provided.
Initial unsolicited report received from a consumer on 13 November 2015. This case involves a 72-year-old female patient who was vaccinated with a dose of FLUZONE QIV (batch number- UI443AB, expiry date-30 June 2016, route and site of administration were not reported) on an unspecified date. The patient's medical history includes illness at time of vaccination, pre-existing physician diagnosed allergies, birth defects, medical conditions and concomitant medications were not reported. On an unspecified date, following the vaccination, the patient had experienced weight loss. The patient was feeling ill and unable to work. Laboratory data and corrective treatment were not reported. The outcome of the event was reported as unknown. List of documents held by sender: none.
I had the 1st dose of the Pfizer Covid vaccine on 4/21/21. I had my 2nd dose on 5/12/21. On 6/5/21 I had the first seizure of my life. I am 39 years old. I did not have any noticeable side effects up to this date. I had felt normal all day. I was driving home at night and remember driving down my long driveway. I have no recollection of actually driving my truck into the back of my husband's car and pushing it through the garage door and halfway into the garage. His car was totaled and my truck and my house (garage door and brick work surrounding the garage) were severely damaged. There is a video of this event on our security system camera. My husband says he came outside to see what happened. He said he opened the truck door. My eyes were glazed over and I was unresponsive. I was still pushing on the gas pedal. He put the truck in park. He helped me out of the truck. There is video of him walking me to the front door. The next thing I remember is being in the house, going to the bathroom and seeing my dogs. After using the bathroom, I went out of the front door. I saw the truck license plate laying the grass and thought that was odd. Then I saw the damaged truck. I looked toward the garage and saw what I thought at the time was a boat. It was really my garage door caved in. I did not go the hospital at that time since I was not injured from the crash. I did not have a migraine or any migraine warning sides all day or any days previously. My head felt normal. I saw my regular doctor on 6/8/21. He was concerned and suggested a MRI. I had my MRI on 6/14/21 and it showed a normal healthy brain. I was referred to a neurologist who I saw on 8/13/21. He thought what I described to him was a seizure and recommended an EEG. I had this EEG on 8/16/21. It showed abnormal brain activity and he said I had partial epilepsy. By 8/20 I was placed on anti-seizure medicine. I have not had any seizures since 6/5. My life has been challenging since I am now unable to drive for six months since the seizure occurred. I have not been against the COVID-19 vaccine and willingly accepted it in April. I do not speak negatively about the vaccine to others. It is interesting though that I have talked to other adults who had the first seizures of their lives after taking this vaccine. In my case I was lucky that this event happened in my yard and I did not harm anyone else and only damaged my own property. They claim I now have partial epilepsy (i.e. only one seizure).
On 9/2/2018 I gave a Hep A vaccine to the pt. then when I was charting realized vaccine expired 09/02/2018.
positive for Covid and they were vaccinated; positive for COVID and they were vaccinated; This is a spontaneous report from Pfizer sponsored Program. A non-contactable consumer reported for patient (mother-in-laws).  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical and concomitant medications were not reported. on an unspecified date, the patient was tested positive for covid and she was vaccinated. It was reported that reporter was not sure how to comment on that but as far as know reporter in laws were tested positive for Covid and they were vaccinated. The patient underwent lab tests and procedures which included sars-cov-2 test, which was positive, on an unknown date. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
10 minutes post vax, the pt developed erythema and slight edema to the IPV injection site. Ice was applied.
This retrospective cohort study report has been received from the authors of a published literature. This paper described a 9.5-year cohort study evaluating the incidence of herpes zoster after concomitant administration of ZOSTAVAX (ZVL) and PNEUMOVAX 23 (PPSV 23).  A retrospective cohort study was conducted from 01-JAN-2007 to 30-JUN-2016. The exposed cohort (concomitant vaccination group) consisted of 60 years of age and older who were vaccinated with ZVL and PPSV23 on the same day from 01-JAN-2007 to 31-DEC-2014. The comparator cohort (prior vaccination group) consisted of 60 years of age and older who were vaccinated with ZVL during the same period as the exposed cohort but were previously vaccinated with a dose of PPSV 23 from 365 days to 30 days prior to receiving ZVL. Both groups had been continuous members in the year prior to date of ZVL vaccination, allowing for a 31-day gap in membership. The patients from both groups were followed from the date of ZVL vaccination until the date of herpes zoster occurrence, termination of membership (allowing for a 31-day gap), death, or 30-JUN-2016, whichever was earliest. This report refers to 137 adult patients (60 year old to 64 year old). On unknown dates the patients were previously vaccinated with a dose of PNEUMOVAX 23 (lot#, expiration date, dose, route and frequency unknown) from 365 days to 30 days prior to receiving ZOSTAVAX (lot#, expiration date, dose, route and frequency unknown) for prophylaxis. On unknown dates, the patients experienced incident severe herpes zoster. The outcome of drug the events was unknown. The reporter considered vaccination failure and herpes zoster to be related ZOSTAVAX. This is one of several reports received from the same literature (linked report MARRS #1804USA008699, 1804USA010349, 1804USA010351, 1804USA010352, 1804USA010377).
Sore throat; Sinus pressure; Painful eyes; Cough; Chest tightness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration on 07May2021 at 13:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08May2021 at 22:00, the patient experienced sore throat, sinus pressure, painful eyes, cough, chest tightness and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore throat, sinus pressure, painful eyes, cough, chest tightness and headache were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
This case was reported by a pharmacist via call center representative and described the occurrence of contusion in a adult patient who received SHINGRIX for prophylaxis. On 22nd June 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, 1 day 12 hrs after receiving SHINGRIX, the patient experienced contusion, tenderness and axillary lump. On an unknown date, the outcome of the contusion, tenderness and axillary lump were unknown. It was unknown if the reporter considered the contusion, tenderness and axillary lump to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. Beginning 36 hours after receiving the vaccine, the patient developed a knot under the armpit, bruising under the armpit, and the armpit area was tender. The patient was seen by here primary doctor, but not emergency room visit or hospitalization was required. The health care professional reported that the patient's primary doctor believed, a blood vessel may had been hit during administration of the vaccine.
Patient received first dose on 20Jan2023; No adverse event; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (Patient received first dose on 20Jan2023) and NO ADVERSE EVENT (No adverse event) in a 35-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Jan-2023, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (Patient received first dose on 20Jan2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (Patient received first dose on 20Jan2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTRATION INTERRUPTED (Patient received first dose on 20Jan2023).    No concomitant medication details was reported. No treatment medication details was reported.
He can barely little walk/He can't barely even stand as just fine; He just have muscle pain.; Chills; His whole body is actually, fever degree high; Swelling; My brother is feeling very sick; This is a spontaneous report from a contactable consumer reported for a male patient (reporter's brother). A male patient of unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0167; Expiration Date: Aug2021, NDC number, UPC number: Unknown) via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Reporter stated was actually calling on behalf of brother because he (patient) recently just got his 2nd shot of the vaccine and reporter was looking at all the side effects that was but just found out that patient had muscle pain but he, like he can barely little walk/ cannot barely even stand as just fine (on an unspecified date). Reporter was taking the patient to the hospital, but he was. The reporter asked to tell because patient just have muscle pain, rest have chills. Reporter check his temperature his whole body was actually, fever degree high, he was swelling (on an unspecified date). When confirmed the name of vaccine as Pfizer Covid 19 vaccine: Reporter stated believe that this was 2nd shot, checked the paper for they gave him it said not, somebody was going to taking to but, what had right now was the Pfizer, looking at the paper that they gave him and just trying (Further clarification was unknown hence was captured as Unspecified medication) Reporter stated just wanted to make sure brother (patient) was okay. Asked if patient should be taken to the hospital, do not need to waste 8 minutes of this time. Well, need to take him hospital. That what reporter said, have been on phone with you from almost 11 minutes now, and needed confirmation was very upset because brother was feeling very sick right (on an unspecified date) was super upset and had number. Reporter was informed about the Medical Information department and Reporter said that Yes, they knew to take him (patient) to the hospital, How could their phone number when supposed to be the 1st person that was supposed to take care of this situation, would go ahead and take the patient to hospital rather that stay her and dial number and wait 8 minutes. Outcome of all events was unknown.   Follow-up attempts are completed. No further information is expected.
Patient is 17 years and 8 months (not 18 years of age as required for Moderna vaccine). No adverse reaction.
pt had red, swollen area @ site inj-rt deltoid w/in several hr felt less swollen used cold compressed smaller today 17NOV97;small bump w/o itching;
pt in Hospice at facility, terminally ill due to COVID pneumonia, sacral and bilateral hip wounds, dementia; pt experiencing dyspnea; decrease in oral intake; bed confined with foley catheter; pt's condition worsened and she passed away in hospice
After getting my second shot of Pfizer COVID vaccine, I waited for 30 minutes according to the protocol and I left for home after the wait. While on the way home, I developed rash on my both arms and felt dizzy. I pulled over to a parking lot but before I could park my car, I passed out. I couldn't control my car and I bumped into another parked car. All this happened in a matter of 15 seconds. My wife and my daughter was with me. When I regained consciousness, my wife was doing CPR on. A bystander in the parking lot called EMS for me.
12 hours in I couldn't stand up, feverish by the morning it had gotten worse could only walk to bathroom and bed.  Couldn't eat but drink. I should've have taken the vacinne  Can't take Motrin can only take tylenol. Bad headache Wednesday my fever finally broke.  Went to sleep and when I woke up I was wet from head to toe. I was able to eat Wednesday and the headache wasn't that bad  Thursday I stayed in bed Friday slept all day headache  was okay and finally able to move around.  At the injection site it was very hot and I couldn't move it.  Could barely move my arm. For about 2 weeks then after that it got itchy.
10:00 am 11/28/11 - 15 mo immunizations received PM 11/28/11 - clonic tonic seizure activity = 911. Admitted to PICU & intubation, fever and seizure activity.
Diagnosis of Infantle Spasms 4/28/07within days after vaccination stopped developing normally, bagan screaming at night and then began regressing developmentally.  After diagnosis, began having spasms.  Was treated with ACTH for 13 weeks, EEG normalized and spasms stopped.  Now taking topamax, but still rarely having spasms, and developmentally delayed.  7/20/07 Received PCP medical records & vax records which provide lot #s.  VAERS database updated w/same.  Office note of 2/15 reveals patient had slight runny nose & cough.  RTC 3/15 for c/o evening fussiness/screaming/pulling legs & arms in & crying when laid flat.  DX w/possible GER & given trial of meds.RTC 3/26 w/o improvement & now w/glazed over staring spells.  Referred for neuro consult, EEG & CT scan.  4/19/07 GER & infantile spasms improving/meds.  Neuro consult done 3/28/07 revealed loss of speech, smile & started screaming approx 2 wks s/p vax.  Admitted to hospital 3/28-3/30 for initiation of ACTH injections & additional w/u.  Close neuro f/u upon d/c w/serial labs & EEGs.  Ophthalmology consult done.  Gradually improved w/decreased spasm & improved EEG & ACTH was being weaned as of 6/29. FINAL DX: Infantile spasms & GERD. 7/27/07 Received hospital medical records which reveal patient experienced loss of developmental milestones & muscle spasms of extremities.  Admitted 3/28-3/30/07.  Tolerated tx well & parents were to admin injections at d/c.   Neuro consult done. FINAL DX: Infantile Spasms. 1/11/2010 Patient continues to suffer from seizures daily that have so far failed to respond to multiple medications. She is also developmentally delayed-at about a 4-6 month level (she is almost 2 yrs old). 02/02/2010 Infantile spasms- a progressive neuropathy. Patient is still having spasms, there is a very high likelyhood that her Infantile spasms will evolve into a lifelong seizure disorder.
In November I thought I had a UTI and went to the doctor and they did a few tests and it wasn't a UTI. I went to see a doctor for the 2nd time, and they did some blood work and noticed my GFR, creatine and A1C had gone up.
body aches, 101 fever. severe malaise, fatigue, headache, nausea. Lasted 3 days
Myalgia, Arthralgia, Fever, UrticariaPrurtis, Swelling at injection site on day 5 and 6. Chills on day 1 and 2. Narrative  No SE on day of injection, on day 2-3 developed chills, malaise, and  subjective low grade fever. On day 4 was "perfectly fine, all resolved". On Day 5, "itching and warmth on injection site with swelling" On assessment today on Day 6, has erythema, warmth edema on right deltoid are measuring 50mm x 70mm. Endorses h/o Contact Dermatitis and "sensitive skin". Area non-tender
Right arm swelling from shoulder through elbow with minimal erythema. No fever or streaks. Received DTaP and IPV in arm.
This spontaneous prospective pregnancy report was received from a registered nurse, for GARDASIL, a Pregnancy Registry product, refers to an approximately 16-year-old female patient with no drug reactions/allergies. This is patient's first pregnancy. On 04-OCT-2012 the patient was vaccinated with dose 2 GARDASIL (lot # not reported) dose and route not reported. No other co-suspects were reported. Concomitant vaccines included meningococcal vaccine (unspecified) (manufacturer unknown) and FLUMIST given on the same date. Approximately on 10-OCT-2012 the patient found out that she was pregnant. Her Last Menstrual Period (LMP) was on 23-AUG-2012 with an estimated delivery date (EDD) of 30-MAY-2013. Patient was scheduled for an ultrasound on 13-NOV-2012. The patient received 1st and 2nd doses of GARDASIL at physician's office. There was an unspecified physician for that facility. The patient had an appointment with an unspecified specialist but then she moved to another state and was being seen at this office. No treatment was given. Patient sought medical attention. Follow-up information was received on 14-FEB-2013 from the registered nurse. The GARDASIL was not continued. During pregnant, the patient also took pyridoxine (P. N vitamin) (oral, one dose a day for pregnant, start date unknown). On 10-OCT-2012, gestational age was 7 weeks 2 days, patient weight was 139, blood pressure was 127/75, leukocyte was negative, blood test was negative, and ketones was negative. Denied contractions (CTX), vaginal birth (VB), or range of motion (ROM). Vomiting but able to keep some liquid and solids down. Discussed maternal fetal medicine (MFM) for vaccination with live viruses in early pregnancy. Ultrasound on 13-NOV-2012 (week 11) was normal. Ultrasound on 08-JAN-2013 (week 19) was normal. Pregnancy was ongoing. Estimated delivery date (EDD) was on 30-MAY-2013 (also reported as 27-MAY-2013). Additional information has been requested.
Patient called and complained of severe muscle pain in his left shoulder and that he could not use his left arm at all, he said that he had to use his right arm to move his left arm. He also stated that the immunization given into his left arm muscle was injected near the shoulder and may have hit bone or a nerve.
Intense body aches and pains especially in the legs. Extreme Fatigue and Lethargy.
Severe hand tremors, weakness in legs, fatigue, irritability-ongoing since right after the second shot.  1 incident of vomiting.